The Wait is Over. Or Is It? DEA’s Proposed Rules Around Telemedicine Prescribing: Initial Impressions and Key Takeaways
Health Law Advisor
MARCH 7, 2023
a cross-coverage situation), or where a practitioner is engaged in the “practice of telemedicine,” e.g. because the patient was physically located in a DEA-registered hospital, clinic, or physician’s office. DEA has specifically requested feedback on whether it should limit telemedicine prescribing to only the drug’s FDA-approved indications.
Let's personalize your content